Benzodiazepine (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Benzodiazepine" in Italian language version.

refsWebsite

Global rank Italian rank

84nih.gov

4^th place

9^th place

59doi.org

2^nd place

7^th place

42oadoi.org

799^th place

22^nd place

23archive.org

6^th place

8^th place

19web.archive.org

1^st place

8books.google.com

3^rd place

14^th place

4benzo.org.uk

low place

4webcitation.org

24^th place

48^th place

2aafp.org

1,916^th place

4,345^th place

1google.ca

838^th place

542^nd place

1choosingwisely.org

7,197^th place

low place

1psychiatryonline.com

low place

1worldcat.org

5^th place

26^th place

1unibo.it

4,963^rd place

325^th place

1mja.com.au

low place

7,873^rd place

1rcpsych.org

low place

6,217^th place

1nature.com

234^th place

226^th place

1whoindia.org

low place

1medscape.com

719^th place

799^th place

1bmj.com

1,226^th place

928^th place

1aappublications.org

3,763^rd place

5,566^th place

1rxlist.com

7,927^th place

low place

1psychiatryonline.org

4,032^nd place

3,374^th place

1parliament.uk

367^th place

1,105^th place

1homeoffice.gov.uk

low place

aafp.org

Ramakrishnan K, Scheid DC, Treatment options for insomnia, in American Family Physician, vol. 76, n. 4, agosto 2007, pp. 517–26, PMID 17853625.
Ebell MH, Benzodiazepines for alcohol withdrawal, in American Family Physician, vol. 73, n. 7, aprile 2006, p. 1191, PMID 16623205.

aappublications.org

pediatrics.aappublications.org

American Academy of Pediatrics Committee on Drugs, Neonatal drug withdrawal (PDF), in Pediatrics, vol. 101, n. 6, 1998, pp. 1079–88, PMID 9614425.

archive.org

Shorter E, Benzodiazepines, in A Historical Dictionary of Psychiatry, Oxford University Press, 2005, pp. 41–2, ISBN 0-19-517668-5.
Ashton H, Benzodiazepine dependence, in Haddad P, Dursun S, Deakin B (eds.) (a cura di), Adverse Syndromes and Psychiatric Drugs: A Clinical Guide, Oxford University Press, 2004, pp. 239–60, ISBN 978-0-19-852748-0.
McIntosh A, Semple D, Smyth R, Burns J, Darjee R, Depressants, in Oxford Handbook of Psychiatry, 1st, Oxford University Press, 2005, p. 540, ISBN 0-19-852783-7.
White JM, Irvine RJ, Mechanisms of fatal opioid overdose, in Addiction, vol. 94, n. 7, 1999, pp. 961–72, DOI:10.1046/j.1360-0443.1999.9479612.x, PMID 10707430.
British National Formulary, p. 189. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
British National Formulary. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
British National Formulary, p. 275. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
British National Formulary, p. 693. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
British National Formulary, pp. 577-578. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
Mañon-Espaillat R, Mandel S, Diagnostic algorithms for neuromuscular diseases, in Clin Podiatr Med Surg, vol. 16, n. 1, 1999, pp. 67–79, PMID 9929772.
Curtin F, Schulz P, Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis, in J Affect Disord, vol. 78, n. 3, 2004, pp. 201–8, DOI:10.1016/S0165-0327(02)00317-8, PMID 15013244.
British National Formulary, p. 204. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
Meyler L, Aronson JK (a cura di), Meyler's Side Effects of Drugs: the International Encyclopedia of Adverse Drug Reactions and Interactions, 15th, Elsevier, 2006, pp. 429–43, ISBN 0-444-50998-4.
Moody D, Drug interactions with benzodiazepines, in Raymon LP, Mozayani A (eds.) (a cura di), Handbook of Drug Interactions: a Clinical and Forensic Guide, Humana, 2004, pp. 3–88, ISBN 1-58829-211-8.
Rapoport MJ, Lanctôt KL, Streiner DL, Bédard M, Vingilis E, Murray B, Schaffer A, Shulman KI, Herrmann N, Benzodiazepine use and driving: a meta-analysis, in J Clin Psychiatry, vol. 70, n. 5, 2009, pp. 663–73, DOI:10.4088/JCP.08m04325, PMID 19389334.
British National Formulary, pp. 183–189. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
Ashton H, Drug dependency: benzodiazepines, in Ayers S, Baum A, McManus C, Newman S (eds.) (a cura di), Cambridge Handbook of Psychology, Health and Medicine, 2nd, Cambridge University Press, 2007, pp. 675–8, ISBN 978-0-521-87997-2.
Harrison PC, Gelder MG, Cowen P, The misuse of alcohol and drugs, in Shorter Oxford Textbook of Psychiatry, 5th, Oxford University Press, 2006, pp. 461–2, ISBN 0-19-856667-0.
British National Formulary, pp. 183–184. (EN) Royal Pharmaceutical Society of Great Britain, British National Formulary (BNF 57), BMJ Group and RPS Publishing, 2009, ISBN 978-0-85369-845-6.
Tariq SH, Pulisetty S, Pharmacotherapy for insomnia, in Clin Geriatr Med, vol. 24, n. 1, 2008, pp. 93–105, vii, DOI:10.1016/j.cger.2007.08.009, PMID 18035234.
Snowden M, Sato K, Roy-Byrne P, Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature, in J Am Geriatr Soc, vol. 51, n. 9, 2003, pp. 1305–17, DOI:10.1046/j.1532-5415.2003.51417.x, PMID 12919245.
Kahn CM, Line S, Aiello SE (a cura di), The Merck Veterinary Manual, 9th, Wiley, 2005, ISBN 978-0-911910-50-6.
Gross ME, Tranquilizers, α₂-adrenergic agonists, and related agents, in Adams RH (ed.) (a cura di), Veterinary Pharmacology and Therapeutics, 8th, Iowa State University Press, 2001, pp. 325–33, ISBN 0-8138-1743-9.

benzo.org.uk

Ashton H, The diagnosis and management of benzodiazepine dependence (PDF), in Current Opinion in Psychiatry, vol. 18, n. 3, 2005, pp. 249–55, DOI:10.1097/01.yco.0000165594.60434.84, PMID 16639148.
Ashton H, Protracted withdrawal syndromes from benzodiazepines, in J Subst Abuse Treat, vol. 8, 1–2, 1991, pp. 19–28, DOI:10.1016/0740-5472(91)90023-4, PMID 1675688.
Ashton CH, Benzodiazepines: how they work & how to withdraw (aka The Ashton Manual), 2002. URL consultato il 27 maggio 2009.
Benzodiazepine abuse, su benzo.org.uk. URL consultato il 28 novembre 2011.

bmj.com

Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR, Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies (PDF), in BMJ, vol. 317, n. 7162, settembre 1998, pp. 839–43, DOI:10.1136/bmj.317.7162.839, PMC 31092, PMID 9748174.

books.google.com

Roland D. Maiuro PhD, Handbook of Integrative Clinical Psychology, Psychiatry, and Behavioral Medicine: Perspectives, Practices, and Research, Springer Publishing Company, 13 dicembre 2009, pp. 128–30, ISBN 0-8261-1094-0.
The American Psychiatric Publishing Textbook of Psychopharmacology, Fourth, American Psychiatric Publishing, 6 maggio 2009, p. 470, ISBN 978-1-58562-309-9.
Hammersley D, Beeley L, The effects of medication on counselling, in Palmer S, Dainow S, Milner P (a cura di), Counselling: The BACP Counselling Reader, vol. 1, Sage, 1996, pp. 211–4, ISBN 978-0-8039-7477-7.
Judith Collier, Murray Longmore e Keith Amarakone, Psychiatry, in Oxford Handbook of Clinical Specialties, OUP Oxford, 31 gennaio 2013, p. 368, ISBN 978-0-19-150476-1.
Manuchair Ebadi, Alphabetical presentation of drugs, in Desk Reference for Clinical Pharmacology, 2nd, USA, CRC Press, 23 ottobre 2007, p. 512, ISBN 978-1-4200-4743-1.
Stephen G. Jackson, Paul Jansen e Arduino Mangoni, Prescribing for Elderly Patients, Wiley, 22 maggio 2009, pp. 47–48, ISBN 0-470-02428-3.
Thomas C. Rosenthal, Mark Williams e Bruce J. Naughton, Office care geriatrics, Philadelphia, Lippincott Williams Wilkins, 2006, pp. 260–262, ISBN 0-7817-6196-4.
Steven B. Karch, Drug Abuse Handbook, 2nd, United States of America, CRC Press, 20 dicembre 2006, p. 217, ISBN 978-0-8493-1690-6.

choosingwisely.org

American Geriatrics Society, Five Things Physicians and Patients Should Question, in Choosing Wisely: an initiative of the ABIM Foundation, American Geriatrics Society. URL consultato il 1º agosto 2013., which cites
- Finkle WD, Der JS, Greenland S, Adams JL, Ridgeway G, Blaschke T, Wang Z, Dell RM, VanRiper KB, Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older Adults, in Journal of the American Geriatrics Society

doi.org

dx.doi.org

Olkkola KT, Ahonen J, Midazolam and other benzodiazepines, in Handb Exp Pharmacol, Handbook of Experimental Pharmacology, vol. 182, n. 182, 2008, pp. 335–60, DOI:10.1007/978-3-540-74806-9_16, ISBN 978-3-540-72813-9, PMID 18175099.
(FR) Saïas T, Gallarda T, [Paradoxical aggressive reactions to benzodiazepine use: a review], in Encephale, vol. 34, n. 4, 2008, pp. 330–6, DOI:10.1016/j.encep.2007.05.005, PMID 18922233.
Lader M, Effectiveness of benzodiazepines: do they work or not? (PDF), in Expert Rev Neurother, vol. 8, n. 8, 2008, pp. 1189–91, DOI:10.1586/14737175.8.8.1189, PMID 18671662.
Lader M, Tylee A, Donoghue J, Withdrawing benzodiazepines in primary care, in CNS Drugs, vol. 23, n. 1, 2009, pp. 19–34, DOI:10.2165/0023210-200923010-00002, PMID 19062773.
Ashton H, The diagnosis and management of benzodiazepine dependence (PDF), in Current Opinion in Psychiatry, vol. 18, n. 3, 2005, pp. 249–55, DOI:10.1097/01.yco.0000165594.60434.84, PMID 16639148.
American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics, ACOG Practice Bulletin no. 92: Use of psychiatric medications during pregnancy and lactation, in Obstet Gynecol, vol. 111, n. 4, aprile 2008, pp. 1001–20, DOI:10.1097/AOG.0b013e31816fd910, PMID 18378767. URL consultato il 29 aprile 2019 (archiviato dall'url originale il 6 luglio 2016).
Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M, A systematic review of research examining benzodiazepine-related mortality, in Pharmacoepidemiol Drug Saf, vol. 18, n. 2, 2009, pp. 93–103, DOI:10.1002/pds.1694, PMID 19125401.
White JM, Irvine RJ, Mechanisms of fatal opioid overdose, in Addiction, vol. 94, n. 7, 1999, pp. 961–72, DOI:10.1046/j.1360-0443.1999.9479612.x, PMID 10707430.
Lader MH, Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?, in E ur Neuropsychopharmacol, vol. 9, Suppl 6, 1999, pp. S399–405, DOI:10.1016/S0924-977X(99)00051-6, PMID 10622686.
Perugi G, Frare F, Toni C, Diagnosis and treatment of agoraphobia with panic disorder, in CNS Drugs, vol. 21, n. 9, 2007, pp. 741–64, DOI:10.2165/00023210-200721090-00004, PMID 17696574.
Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C, Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials, in J. Psychopharmacol. (Oxford), vol. 21, n. 7, settembre 2007, pp. 774–82, DOI:10.1177/0269881107077355, PMID 17881433.
B Bandelow, M Reitt, C Röver, S Michaelis, Y Görlich e D Wedekind, Efficacy of treatments for anxiety disorders: a meta-analysis., in International clinical psychopharmacology, vol. 30, n. 4, luglio 2015, pp. 183–92, DOI:10.1097/yic.0000000000000078, PMID 25932596.
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders, in The World Journal of Biological Psychiatry, vol. 3, n. 4, Informa Healthcare, ottobre 2002, pp. 171–99, DOI:10.3109/15622970209150621, PMID 12516310.
Cloos JM, Ferreira V, Current use of benzodiazepines in anxiety disorders, in Current Opinion in Psychiatry, vol. 22, n. 1, 2009, pp. 90–95, DOI:10.1097/YCO.0b013e32831a473d, PMID 19122540.
Shorvon SD, Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959–2009, in Epilepsia, vol. 50, Suppl 3, marzo 2009, pp. 93–130, DOI:10.1111/j.1528-1167.2009.02042.x, PMID 19298435.
Ashworth M, Gerada C, ABC of mental health. Addiction and dependence—II: Alcohol, in BMJ, vol. 315, n. 7104, 1997, pp. 358–60, DOI:10.1136/bmj.315.7104.358, PMC 2127236, PMID 9270461.
Kraemer KL, Conigliaro J, Saitz R, Managing alcohol withdrawal in the elderly, in Drugs Aging, vol. 14, n. 6, 1999, pp. 409–25, DOI:10.2165/00002512-199914060-00002, PMID 10408740.
Devlin JW, Roberts RJ, Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids, in Crit Care Clin, vol. 25, n. 3, luglio 2009, pp. 431–49, vii, DOI:10.1016/j.ccc.2009.03.003, PMID 19576523.
Broscheit J, Kranke P, [The preoperative medication: background and specific indications for the selection of the drugs], in Anasthesiol Intensivmed Notfallmed Schmerzther, vol. 43, n. 2, febbraio 2008, pp. 134–43, DOI:10.1055/s-2008-1060547, PMID 18293248.
Kamen L, Henney HR, Runyan JD, A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury, in Curr Med Res Opin, vol. 24, n. 2, febbraio 2008, pp. 425–39, DOI:10.1185/030079908X261113, PMID 18167175.
Zimbroff DL, Pharmacological control of acute agitation: focus on intramuscular preparations, in CNS Drugs, vol. 22, n. 3, 2008, pp. 199–212, DOI:10.2165/00023210-200822030-00002, PMID 18278976.
Curtin F, Schulz P, Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis, in J Affect Disord, vol. 78, n. 3, 2004, pp. 201–8, DOI:10.1016/S0165-0327(02)00317-8, PMID 15013244.
Gillies D, Beck A, McCloud A, Rathbone J, Gillies D, Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis, in Cochrane Database of Systematic Reviews, n. 4, 2005, pp. CD003079, DOI:10.1002/14651858.CD003079.pub2, PMID 16235313.
(PT) Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI), Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros [Restless legs syndrome: diagnosis and treatment. Opinion of Brazilian experts], in Arq. Neuro-Psiquiatr., vol. 65, 3a, settembre 2007, pp. 721–7, DOI:10.1590/S0004-282X2007000400035, ISSN 0004-282X (WC · ACNP), PMID 17876423.
Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C, Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice (PDF), in Mov Disord, vol. 23, n. 16, dicembre 2008, pp. 2267–302, DOI:10.1002/mds.22254, PMID 18925578 (archiviato dall'url originale il 29 dicembre 2009).
Attard A, Ranjith G, Taylor D, Delirium and its treatment, in CNS Drugs, vol. 22, n. 8, agosto 2008, pp. 631–44, DOI:10.2165/00023210-200822080-00002, PMID 18601302.
Gallegos J, Vaidya P, D'Agati D, Jayaram G, Nguyen T, Tripathi A, Trivedi JK, Reti IM, Decreasing adverse outcomes of unmodified electroconvulsive therapy: suggestions and possibilities, in J ECT, vol. 28, n. 2, giugno 2012, pp. 77–81, DOI:10.1097/YCT.0b013e3182359314, PMID 22531198.
Stone KL, Ensrud KE, Ancoli-Israel S, Sleep, insomnia and falls in elderly patients, in Sleep Med., 9 Suppl 1, settembre 2008, pp. S18–22, DOI:10.1016/S1389-9457(08)70012-1, PMID 18929314.
Rapoport MJ, Lanctôt KL, Streiner DL, Bédard M, Vingilis E, Murray B, Schaffer A, Shulman KI, Herrmann N, Benzodiazepine use and driving: a meta-analysis, in J Clin Psychiatry, vol. 70, n. 5, 2009, pp. 663–73, DOI:10.4088/JCP.08m04325, PMID 19389334.
Orriols L, Salmi LR, Philip P, Moore N, Delorme B, Castot A, Lagarde E, The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies, in Pharmacoepidemiol Drug Saf, vol. 18, n. 8, 2009, pp. 647–58, DOI:10.1002/pds.1763, PMC 2780583, PMID 19418468.
Riss J, Cloyd J, Gates J, Collins S, Benzodiazepines in epilepsy: pharmacology and pharmacokinetics, in Acta Neurol Scand, vol. 118, n. 2, agosto 2008, pp. 69–86, DOI:10.1111/j.1600-0404.2008.01004.x, PMID 18384456.
Paton C, Benzodiazepines and disinhibition: a review (PDF), in Psychiatr Bull R Coll Psychiatr, vol. 26, n. 12, 2002, pp. 460–2, DOI:10.1192/pb.26.12.460.
Bond AJ, Drug-induced behavioural disinhibition: incidence, mechanisms and therapeutic implications, in CNS Drugs, vol. 9, n. 1, 1998, pp. 41–57, DOI:10.2165/00023210-199809010-00005.
Golombok S, Moodley P, Lader M, 2, in Cognitive impairment in long-term benzodiazepine users, Psychological Medicine, vol. 18, May 1988, p. 365–74, DOI:10.1017/S0033291700007911, PMID 2899898.
Nardi AE, Perna G, Clonazepam in the treatment of psychiatric disorders: an update, in Int Clin Psychopharmacol, vol. 21, n. 3, maggio 2006, pp. 131–42, DOI:10.1097/01.yic.0000194379.65460.a6, PMID 16528135.
Ashton H, Protracted withdrawal syndromes from benzodiazepines, in J Subst Abuse Treat, vol. 8, 1–2, 1991, pp. 19–28, DOI:10.1016/0740-5472(91)90023-4, PMID 1675688.
Fraser AD, Use and abuse of the benzodiazepines, in Ther Drug Monit, vol. 20, n. 5, 1998, pp. 481–9, DOI:10.1097/00007691-199810000-00007, PMID 9780123.
Gaudreault P, Guay J, Thivierge RL, Verdy I, Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment, in Drug Saf, vol. 6, n. 4, 1991, pp. 247–65, DOI:10.2165/00002018-199106040-00003, PMID 1888441.
Klein-Schwartz W, Oderda GM, Poisoning in the elderly. Epidemiological, clinical and management considerations, in Drugs Aging, vol. 1, n. 1, 1991, pp. 67–89, DOI:10.2165/00002512-199101010-00008, PMID 1794007.
Buckley NA, Dawson AH, Whyte IM, O'Connell DL, Relative toxicity of benzodiazepines in overdose, in BMJ, vol. 310, n. 28, 1995, pp. 219–221, DOI:10.1136/bmj.310.6974.219, PMC 2548618, PMID 7866122.
Serfaty M, Masterton G, Fatal poisonings attributed to benzodiazepines in Britain during the 1980s, in British Journal of Psychiatry, vol. 163, n. 1, 1994, pp. 128–9, DOI:10.1192/bjp.163.3.386, PMID 8104653.
Seger DL, Flumazenil—treatment or toxin, in J Toxicol Clin Toxicol, vol. 42, n. 2, 2004, pp. 209–16, DOI:10.1081/CLT-120030946, PMID 15214628.
Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR, Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies (PDF), in BMJ, vol. 317, n. 7162, settembre 1998, pp. 839–43, DOI:10.1136/bmj.317.7162.839, PMC 31092, PMID 9748174.
Iqbal MM, Sobhan T, Ryals T, Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant (PDF), in Psychiatr Serv, vol. 53, n. 1, 2002, pp. 39–49, DOI:10.1176/appi.ps.53.1.39, PMID 11773648 (archiviato dall'url originale il 27 luglio 2011).
Tariq SH, Pulisetty S, Pharmacotherapy for insomnia, in Clin Geriatr Med, vol. 24, n. 1, 2008, pp. 93–105, vii, DOI:10.1016/j.cger.2007.08.009, PMID 18035234.
Bain KT, Management of chronic insomnia in elderly persons, in Am J Geriatr Pharmacother, vol. 4, n. 2, 2006, pp. 168–92, DOI:10.1016/j.amjopharm.2006.06.006, PMID 16860264.
Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A, Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review, in Drugs Aging, vol. 22, n. 9, 2005, pp. 749–65, DOI:10.2165/00002512-200522090-00004, PMID 16156679.
Khong TP, de Vries F, Goldenberg JS, Klungel OH, Robinson NJ, Ibáñez L, Petri H, Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States, in Calcif. Tissue Int., vol. 91, n. 1, luglio 2012, pp. 24–31, DOI:10.1007/s00223-012-9603-8, PMC 3382650, PMID 22566242.
Bogunovic OJ, Greenfield SF, Practical geriatrics: Use of benzodiazepines among elderly patients (PDF), in Psychiatr Serv, vol. 55, n. 3, 2004, pp. 233–5, DOI:10.1176/appi.ps.55.3.233, PMID 15001721.
Snowden M, Sato K, Roy-Byrne P, Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature, in J Am Geriatr Soc, vol. 51, n. 9, 2003, pp. 1305–17, DOI:10.1046/j.1532-5415.2003.51417.x, PMID 12919245.
Wang PS, Brookhart MA, Setoguchi S, Patrick AR, Schneeweiss S, Psychotropic medication use for behavioral symptoms of dementia, in Curr Neurol Neurosci Rep, vol. 6, n. 6, 2006, pp. 490–5, DOI:10.1007/s11910-006-0051-6, PMID 17074284.
Hulse GK, Lautenschlager NT, Tait RJ, Almeida OP, Dementia associated with alcohol and other drug use, in Int Psychogeriatr, vol. 17, Suppl 1, 2005, pp. S109–27, DOI:10.1017/S1041610205001985, PMID 16240487.
Sternbach LH, The benzodiazepine story, in Journal of Medicinal Chemistry, vol. 22, n. 1, 1979, pp. 1–7, DOI:10.1021/jm00187a001, PMID 34039.
Miller NS, Gold MS, Benzodiazepines: reconsidered, in Adv Alcohol Subst Abuse, vol. 8, 3–4, 1990, pp. 67–84, DOI:10.1300/J251v08n03_06, PMID 1971487.
Lemmer B, The sleep–wake cycle and sleeping pills, in Physiol Behav, vol. 90, 2–3, 2007, pp. 285–93, DOI:10.1016/j.physbeh.2006.09.006, PMID 17049955.
Gerada C, Ashworth M, ABC of mental health. Addiction and dependence—I: Illicit drugs, in BMJ, vol. 315, n. 7103, 1997, pp. 297–300, DOI:10.1136/bmj.315.7103.297, PMC 2127199, PMID 9274553.
Farré M, Camí J, Pharmacokinetic considerations in abuse liability evaluation, in Br J Addict., vol. 86, n. 12, dicembre 1991, pp. 1601–6, DOI:10.1111/j.1360-0443.1991.tb01754.x, PMID 1786493.
Busto U, Sellers EM, Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective, in Clin Pharmacokinet., vol. 11, n. 2, 1986, pp. 144–153, DOI:10.2165/00003088-198611020-00004, PMID 3514044.
Kintz P, Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes, in Anal Bioanal Chem, vol. 388, n. 7, 2007, pp. 1467–74, DOI:10.1007/s00216-007-1209-z, PMID 17340077.

google.ca

books.google.ca

Treating Alcohol and Drug Problems in Psychotherapy Practice Doing What Works., New York, Guilford Publications, 2011, p. 47, ISBN 978-1-4625-0438-1.

homeoffice.gov.uk

Home Office (2005). Explanatory memorandum to the misuse of drugs and the misuse of drugs Archiviato il 16 dicembre 2010 in Internet Archive. (supply to addicts) (amendment) regulations 2005.No.2864. Accessed 20–10–03

medscape.com

emedicine.medscape.com

Robin Mantooth, Toxicity, benzodiazepine, su eMedicine, 28 gennaio 2010. URL consultato il 2 ottobre 2010.

mja.com.au

Norman TR, Ellen SR, Burrows GD, Benzodiazepines in anxiety disorders: managing therapeutics and dependence (PDF), in Med J Aust, vol. 167, n. 9, 1997, pp. 490–5, PMID 9397065.

nature.com

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota, su Nature

nih.gov

ncbi.nlm.nih.gov

Olkkola KT, Ahonen J, Midazolam and other benzodiazepines, in Handb Exp Pharmacol, Handbook of Experimental Pharmacology, vol. 182, n. 182, 2008, pp. 335–60, DOI:10.1007/978-3-540-74806-9_16, ISBN 978-3-540-72813-9, PMID 18175099.
(FR) Saïas T, Gallarda T, [Paradoxical aggressive reactions to benzodiazepine use: a review], in Encephale, vol. 34, n. 4, 2008, pp. 330–6, DOI:10.1016/j.encep.2007.05.005, PMID 18922233.
Lader M, Effectiveness of benzodiazepines: do they work or not? (PDF), in Expert Rev Neurother, vol. 8, n. 8, 2008, pp. 1189–91, DOI:10.1586/14737175.8.8.1189, PMID 18671662.
Lader M, Tylee A, Donoghue J, Withdrawing benzodiazepines in primary care, in CNS Drugs, vol. 23, n. 1, 2009, pp. 19–34, DOI:10.2165/0023210-200923010-00002, PMID 19062773.
Ashton H, The diagnosis and management of benzodiazepine dependence (PDF), in Current Opinion in Psychiatry, vol. 18, n. 3, 2005, pp. 249–55, DOI:10.1097/01.yco.0000165594.60434.84, PMID 16639148.
American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics, ACOG Practice Bulletin no. 92: Use of psychiatric medications during pregnancy and lactation, in Obstet Gynecol, vol. 111, n. 4, aprile 2008, pp. 1001–20, DOI:10.1097/AOG.0b013e31816fd910, PMID 18378767. URL consultato il 29 aprile 2019 (archiviato dall'url originale il 6 luglio 2016).
Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M, A systematic review of research examining benzodiazepine-related mortality, in Pharmacoepidemiol Drug Saf, vol. 18, n. 2, 2009, pp. 93–103, DOI:10.1002/pds.1694, PMID 19125401.
White JM, Irvine RJ, Mechanisms of fatal opioid overdose, in Addiction, vol. 94, n. 7, 1999, pp. 961–72, DOI:10.1046/j.1360-0443.1999.9479612.x, PMID 10707430.
Lader MH, Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?, in E ur Neuropsychopharmacol, vol. 9, Suppl 6, 1999, pp. S399–405, DOI:10.1016/S0924-977X(99)00051-6, PMID 10622686.
Perugi G, Frare F, Toni C, Diagnosis and treatment of agoraphobia with panic disorder, in CNS Drugs, vol. 21, n. 9, 2007, pp. 741–64, DOI:10.2165/00023210-200721090-00004, PMID 17696574.
Tesar GE, High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience, in J Clin Psychiatry, vol. 51, Suppl, 1990, pp. 4–10; discussion 50–3, PMID 1970816.
Faught E, Treatment of refractory primary generalized epilepsy, in Rev Neurol Dis, vol. 1, Suppl 1, 2004, pp. S34–43, PMID 16400293.
Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP, WCA recommendations for the long-term treatment of generalized anxiety disorder, in CNS Spectr, vol. 8, Suppl 1, 2003, pp. 53–61, PMID 14767398.
Ramakrishnan K, Scheid DC, Treatment options for insomnia, in American Family Physician, vol. 76, n. 4, agosto 2007, pp. 517–26, PMID 17853625.
Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C, Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials, in J. Psychopharmacol. (Oxford), vol. 21, n. 7, settembre 2007, pp. 774–82, DOI:10.1177/0269881107077355, PMID 17881433.
Canadian Psychiatric Association, Clinical practice guidelines. Management of anxiety disorders (PDF), in Can J Psychiatry, vol. 51, 8 Suppl 2, luglio 2006, pp. 51S–55S, PMID 16933543. URL consultato l'8 agosto 2009 (archiviato dall'url originale il 14 luglio 2010).
B Bandelow, M Reitt, C Röver, S Michaelis, Y Görlich e D Wedekind, Efficacy of treatments for anxiety disorders: a meta-analysis., in International clinical psychopharmacology, vol. 30, n. 4, luglio 2015, pp. 183–92, DOI:10.1097/yic.0000000000000078, PMID 25932596.
Stevens JC, Pollack MH, Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents, in Journal of Clinical Psychiatry, vol. 66, Suppl 2, 2005, pp. 21–27, PMID 15762816.
«The frequent use of benzodiazepines for the treatment of anxiety is likely a reflection of their effectiveness, rapid onset of anxiolytic effect, and tolerability.»
Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders, in The World Journal of Biological Psychiatry, vol. 3, n. 4, Informa Healthcare, ottobre 2002, pp. 171–99, DOI:10.3109/15622970209150621, PMID 12516310.
Cloos JM, Ferreira V, Current use of benzodiazepines in anxiety disorders, in Current Opinion in Psychiatry, vol. 22, n. 1, 2009, pp. 90–95, DOI:10.1097/YCO.0b013e32831a473d, PMID 19122540.
Shorvon SD, Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959–2009, in Epilepsia, vol. 50, Suppl 3, marzo 2009, pp. 93–130, DOI:10.1111/j.1528-1167.2009.02042.x, PMID 19298435.
Ashworth M, Gerada C, ABC of mental health. Addiction and dependence—II: Alcohol, in BMJ, vol. 315, n. 7104, 1997, pp. 358–60, DOI:10.1136/bmj.315.7104.358, PMC 2127236, PMID 9270461.
Kraemer KL, Conigliaro J, Saitz R, Managing alcohol withdrawal in the elderly, in Drugs Aging, vol. 14, n. 6, 1999, pp. 409–25, DOI:10.2165/00002512-199914060-00002, PMID 10408740.
Prater CD, Miller KE, Zylstra RG, Outpatient detoxification of the addicted or alcoholic patient, in American Family Physician, vol. 60, n. 4, settembre 1999, pp. 1175–83, PMID 10507746. URL consultato il 23 ottobre 2015 (archiviato dall'url originale il 6 giugno 2011).
Ebell MH, Benzodiazepines for alcohol withdrawal, in American Family Physician, vol. 73, n. 7, aprile 2006, p. 1191, PMID 16623205.
Peppers MP, Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease, in Pharmacotherapy, vol. 16, n. 1, 1996, pp. 49–57, PMID 8700792.
Devlin JW, Roberts RJ, Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids, in Crit Care Clin, vol. 25, n. 3, luglio 2009, pp. 431–49, vii, DOI:10.1016/j.ccc.2009.03.003, PMID 19576523.
Broscheit J, Kranke P, [The preoperative medication: background and specific indications for the selection of the drugs], in Anasthesiol Intensivmed Notfallmed Schmerzther, vol. 43, n. 2, febbraio 2008, pp. 134–43, DOI:10.1055/s-2008-1060547, PMID 18293248.
Berthold C, Enteral sedation: safety, efficacy, and controversy, in Compend Contin Educ Dent, vol. 28, n. 5, maggio 2007, pp. 264–71; quiz 272, 282, PMID 17607891.
Mañon-Espaillat R, Mandel S, Diagnostic algorithms for neuromuscular diseases, in Clin Podiatr Med Surg, vol. 16, n. 1, 1999, pp. 67–79, PMID 9929772.
Kamen L, Henney HR, Runyan JD, A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury, in Curr Med Res Opin, vol. 24, n. 2, febbraio 2008, pp. 425–39, DOI:10.1185/030079908X261113, PMID 18167175.
Zimbroff DL, Pharmacological control of acute agitation: focus on intramuscular preparations, in CNS Drugs, vol. 22, n. 3, 2008, pp. 199–212, DOI:10.2165/00023210-200822030-00002, PMID 18278976.
Curtin F, Schulz P, Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis, in J Affect Disord, vol. 78, n. 3, 2004, pp. 201–8, DOI:10.1016/S0165-0327(02)00317-8, PMID 15013244.
Gillies D, Beck A, McCloud A, Rathbone J, Gillies D, Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis, in Cochrane Database of Systematic Reviews, n. 4, 2005, pp. CD003079, DOI:10.1002/14651858.CD003079.pub2, PMID 16235313.
Schenck CH, Arnulf I, Mahowald MW, Sleep and Sex: What Can Go Wrong? A Review of the Literature on Sleep Related Disorders and Abnormal Sexual Behaviors and Experiences, in Sleep, vol. 30, n. 6, giugno 2007, pp. 683–702, PMC 1978350, PMID 17580590.
(PT) Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI), Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros [Restless legs syndrome: diagnosis and treatment. Opinion of Brazilian experts], in Arq. Neuro-Psiquiatr., vol. 65, 3a, settembre 2007, pp. 721–7, DOI:10.1590/S0004-282X2007000400035, ISSN 0004-282X (WC · ACNP), PMID 17876423.
Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C, Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice (PDF), in Mov Disord, vol. 23, n. 16, dicembre 2008, pp. 2267–302, DOI:10.1002/mds.22254, PMID 18925578 (archiviato dall'url originale il 29 dicembre 2009).
Bandelow B, The medical treatment of obsessive-compulsive disorder and anxiety, in CNS Spectr, vol. 13, 9 Suppl 14, settembre 2008, pp. 37–46, PMID 18849910.
Attard A, Ranjith G, Taylor D, Delirium and its treatment, in CNS Drugs, vol. 22, n. 8, agosto 2008, pp. 631–44, DOI:10.2165/00023210-200822080-00002, PMID 18601302.
Gallegos J, Vaidya P, D'Agati D, Jayaram G, Nguyen T, Tripathi A, Trivedi JK, Reti IM, Decreasing adverse outcomes of unmodified electroconvulsive therapy: suggestions and possibilities, in J ECT, vol. 28, n. 2, giugno 2012, pp. 77–81, DOI:10.1097/YCT.0b013e3182359314, PMID 22531198.
Norman TR, Ellen SR, Burrows GD, Benzodiazepines in anxiety disorders: managing therapeutics and dependence (PDF), in Med J Aust, vol. 167, n. 9, 1997, pp. 490–5, PMID 9397065.
Stone KL, Ensrud KE, Ancoli-Israel S, Sleep, insomnia and falls in elderly patients, in Sleep Med., 9 Suppl 1, settembre 2008, pp. S18–22, DOI:10.1016/S1389-9457(08)70012-1, PMID 18929314.
Rapoport MJ, Lanctôt KL, Streiner DL, Bédard M, Vingilis E, Murray B, Schaffer A, Shulman KI, Herrmann N, Benzodiazepine use and driving: a meta-analysis, in J Clin Psychiatry, vol. 70, n. 5, 2009, pp. 663–73, DOI:10.4088/JCP.08m04325, PMID 19389334.
Orriols L, Salmi LR, Philip P, Moore N, Delorme B, Castot A, Lagarde E, The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies, in Pharmacoepidemiol Drug Saf, vol. 18, n. 8, 2009, pp. 647–58, DOI:10.1002/pds.1763, PMC 2780583, PMID 19418468.
Riss J, Cloyd J, Gates J, Collins S, Benzodiazepines in epilepsy: pharmacology and pharmacokinetics, in Acta Neurol Scand, vol. 118, n. 2, agosto 2008, pp. 69–86, DOI:10.1111/j.1600-0404.2008.01004.x, PMID 18384456.
Golombok S, Moodley P, Lader M, 2, in Cognitive impairment in long-term benzodiazepine users, Psychological Medicine, vol. 18, May 1988, p. 365–74, DOI:10.1017/S0033291700007911, PMID 2899898.
Stewart SA, The effects of benzodiazepines on cognition (PDF), in J Clin Psychiatry, vol. 66, Suppl 2, 2005, pp. 9–13, PMID 15762814 (archiviato dall'url originale il 15 luglio 2011).
H. Ashton, Benzodiazepine withdrawal: an unfinished story, in British Medical Journal, 1984.
Nardi AE, Perna G, Clonazepam in the treatment of psychiatric disorders: an update, in Int Clin Psychopharmacol, vol. 21, n. 3, maggio 2006, pp. 131–42, DOI:10.1097/01.yic.0000194379.65460.a6, PMID 16528135.
Longo LP, Johnson B, Addiction: Part I. Benzodiazepines—side effects, abuse risk and alternatives, in American Family Physician, vol. 61, n. 7, aprile 2000, pp. 2121–8, PMID 10779253. URL consultato il 23 ottobre 2015 (archiviato dall'url originale il 12 maggio 2008).
Otto MW, Bruce SE, Deckersbach T, Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need (PDF), in J Clin Psychiatry, vol. 66, Suppl 2, 2005, pp. 34–8, PMID 15762818 (archiviato dall'url originale il 15 luglio 2011).
Chouinard G, Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound (PDF), in J Clin Psychiatry, vol. 65, Suppl 5, 2004, pp. 7–12, PMID 15078112 (archiviato dall'url originale il 15 luglio 2011).
Ashton H, Protracted withdrawal syndromes from benzodiazepines, in J Subst Abuse Treat, vol. 8, 1–2, 1991, pp. 19–28, DOI:10.1016/0740-5472(91)90023-4, PMID 1675688.
Rebound insomnia: a critical review., su ncbi.nlm.nih.gov.
Fraser AD, Use and abuse of the benzodiazepines, in Ther Drug Monit, vol. 20, n. 5, 1998, pp. 481–9, DOI:10.1097/00007691-199810000-00007, PMID 9780123.
Gaudreault P, Guay J, Thivierge RL, Verdy I, Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment, in Drug Saf, vol. 6, n. 4, 1991, pp. 247–65, DOI:10.2165/00002018-199106040-00003, PMID 1888441.
Klein-Schwartz W, Oderda GM, Poisoning in the elderly. Epidemiological, clinical and management considerations, in Drugs Aging, vol. 1, n. 1, 1991, pp. 67–89, DOI:10.2165/00002512-199101010-00008, PMID 1794007.
Buckley NA, Dawson AH, Whyte IM, O'Connell DL, Relative toxicity of benzodiazepines in overdose, in BMJ, vol. 310, n. 28, 1995, pp. 219–221, DOI:10.1136/bmj.310.6974.219, PMC 2548618, PMID 7866122.
Serfaty M, Masterton G, Fatal poisonings attributed to benzodiazepines in Britain during the 1980s, in British Journal of Psychiatry, vol. 163, n. 1, 1994, pp. 128–9, DOI:10.1192/bjp.163.3.386, PMID 8104653.
Seger DL, Flumazenil—treatment or toxin, in J Toxicol Clin Toxicol, vol. 42, n. 2, 2004, pp. 209–16, DOI:10.1081/CLT-120030946, PMID 15214628.
Treatment of benzodiazepine overdose with flumazenil. The flumazenil in benzodiazepine intoxication multicenter study group, in Clin Ther, vol. 14, n. 6, 1992, pp. 978–95, PMID 1286503.
Spivey WH, Flumazenil and seizures: analysis of 43 cases, in Clin Ther, vol. 14, n. 2, 1992, pp. 292–305, PMID 1611650.
Dolovich LR, Addis A, Vaillancourt JM, Power JD, Koren G, Einarson TR, Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies (PDF), in BMJ, vol. 317, n. 7162, settembre 1998, pp. 839–43, DOI:10.1136/bmj.317.7162.839, PMC 31092, PMID 9748174.
American Academy of Pediatrics Committee on Drugs, Neonatal drug withdrawal (PDF), in Pediatrics, vol. 101, n. 6, 1998, pp. 1079–88, PMID 9614425.
Iqbal MM, Sobhan T, Ryals T, Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant (PDF), in Psychiatr Serv, vol. 53, n. 1, 2002, pp. 39–49, DOI:10.1176/appi.ps.53.1.39, PMID 11773648 (archiviato dall'url originale il 27 luglio 2011).
Tariq SH, Pulisetty S, Pharmacotherapy for insomnia, in Clin Geriatr Med, vol. 24, n. 1, 2008, pp. 93–105, vii, DOI:10.1016/j.cger.2007.08.009, PMID 18035234.
Bain KT, Management of chronic insomnia in elderly persons, in Am J Geriatr Pharmacother, vol. 4, n. 2, 2006, pp. 168–92, DOI:10.1016/j.amjopharm.2006.06.006, PMID 16860264.
Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A, Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review, in Drugs Aging, vol. 22, n. 9, 2005, pp. 749–65, DOI:10.2165/00002512-200522090-00004, PMID 16156679.
Khong TP, de Vries F, Goldenberg JS, Klungel OH, Robinson NJ, Ibáñez L, Petri H, Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States, in Calcif. Tissue Int., vol. 91, n. 1, luglio 2012, pp. 24–31, DOI:10.1007/s00223-012-9603-8, PMC 3382650, PMID 22566242.
Bogunovic OJ, Greenfield SF, Practical geriatrics: Use of benzodiazepines among elderly patients (PDF), in Psychiatr Serv, vol. 55, n. 3, 2004, pp. 233–5, DOI:10.1176/appi.ps.55.3.233, PMID 15001721.
Snowden M, Sato K, Roy-Byrne P, Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature, in J Am Geriatr Soc, vol. 51, n. 9, 2003, pp. 1305–17, DOI:10.1046/j.1532-5415.2003.51417.x, PMID 12919245.
Wang PS, Brookhart MA, Setoguchi S, Patrick AR, Schneeweiss S, Psychotropic medication use for behavioral symptoms of dementia, in Curr Neurol Neurosci Rep, vol. 6, n. 6, 2006, pp. 490–5, DOI:10.1007/s11910-006-0051-6, PMID 17074284.
Hulse GK, Lautenschlager NT, Tait RJ, Almeida OP, Dementia associated with alcohol and other drug use, in Int Psychogeriatr, vol. 17, Suppl 1, 2005, pp. S109–27, DOI:10.1017/S1041610205001985, PMID 16240487.
Sternbach LH, The benzodiazepine story, in Journal of Medicinal Chemistry, vol. 22, n. 1, 1979, pp. 1–7, DOI:10.1021/jm00187a001, PMID 34039.
Miller NS, Gold MS, Benzodiazepines: reconsidered, in Adv Alcohol Subst Abuse, vol. 8, 3–4, 1990, pp. 67–84, DOI:10.1300/J251v08n03_06, PMID 1971487.
King MB, Is there still a role for benzodiazepines in general practice?, in Br J Gen Pract, vol. 42, n. 358, 1992, pp. 202–5, PMC 1372025, PMID 1389432.
Jufe GS, [New hypnotics: perspectives from sleep physiology], in Vertex, vol. 18, n. 74, Jul–Aug 2007, pp. 294–9, PMID 18265473.
Lemmer B, The sleep–wake cycle and sleeping pills, in Physiol Behav, vol. 90, 2–3, 2007, pp. 285–93, DOI:10.1016/j.physbeh.2006.09.006, PMID 17049955.
Gerada C, Ashworth M, ABC of mental health. Addiction and dependence—I: Illicit drugs, in BMJ, vol. 315, n. 7103, 1997, pp. 297–300, DOI:10.1136/bmj.315.7103.297, PMC 2127199, PMID 9274553.
Farré M, Camí J, Pharmacokinetic considerations in abuse liability evaluation, in Br J Addict., vol. 86, n. 12, dicembre 1991, pp. 1601–6, DOI:10.1111/j.1360-0443.1991.tb01754.x, PMID 1786493.
Busto U, Sellers EM, Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective, in Clin Pharmacokinet., vol. 11, n. 2, 1986, pp. 144–153, DOI:10.2165/00003088-198611020-00004, PMID 3514044.
Kintz P, Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes, in Anal Bioanal Chem, vol. 388, n. 7, 2007, pp. 1467–74, DOI:10.1007/s00216-007-1209-z, PMID 17340077.
Frey HH, Anticonvulsant drugs used in the treatment of epilepsy, in Probl Vet Med, vol. 1, n. 4, 1989, pp. 558–77, PMID 2520134.
Podell M, Seizures in dogs, in Vet Clin North Am Small Anim Pract, vol. 26, n. 4, 1996, pp. 779–809, PMID 8813750.

oadoi.org

Olkkola KT, Ahonen J, Midazolam and other benzodiazepines, in Handb Exp Pharmacol, Handbook of Experimental Pharmacology, vol. 182, n. 182, 2008, pp. 335–60, DOI:10.1007/978-3-540-74806-9_16, ISBN 978-3-540-72813-9, PMID 18175099.
(FR) Saïas T, Gallarda T, [Paradoxical aggressive reactions to benzodiazepine use: a review], in Encephale, vol. 34, n. 4, 2008, pp. 330–6, DOI:10.1016/j.encep.2007.05.005, PMID 18922233.
Lader M, Effectiveness of benzodiazepines: do they work or not? (PDF), in Expert Rev Neurother, vol. 8, n. 8, 2008, pp. 1189–91, DOI:10.1586/14737175.8.8.1189, PMID 18671662.
Lader M, Tylee A, Donoghue J, Withdrawing benzodiazepines in primary care, in CNS Drugs, vol. 23, n. 1, 2009, pp. 19–34, DOI:10.2165/0023210-200923010-00002, PMID 19062773.
Charlson F, Degenhardt L, McLaren J, Hall W, Lynskey M, A systematic review of research examining benzodiazepine-related mortality, in Pharmacoepidemiol Drug Saf, vol. 18, n. 2, 2009, pp. 93–103, DOI:10.1002/pds.1694, PMID 19125401.
Lader MH, Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified?, in E ur Neuropsychopharmacol, vol. 9, Suppl 6, 1999, pp. S399–405, DOI:10.1016/S0924-977X(99)00051-6, PMID 10622686.
Perugi G, Frare F, Toni C, Diagnosis and treatment of agoraphobia with panic disorder, in CNS Drugs, vol. 21, n. 9, 2007, pp. 741–64, DOI:10.2165/00023210-200721090-00004, PMID 17696574.
American Geriatrics Society, Five Things Physicians and Patients Should Question, in Choosing Wisely: an initiative of the ABIM Foundation, American Geriatrics Society. URL consultato il 1º agosto 2013., which cites
- Finkle WD, Der JS, Greenland S, Adams JL, Ridgeway G, Blaschke T, Wang Z, Dell RM, VanRiper KB, Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older Adults, in Journal of the American Geriatrics Society
- Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C, Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials, in J. Psychopharmacol. (Oxford), vol. 21, n. 7, settembre 2007, pp. 774–82, DOI:10.1177/0269881107077355, PMID 17881433.
- B Bandelow, M Reitt, C Röver, S Michaelis, Y Görlich e D Wedekind, Efficacy of treatments for anxiety disorders: a meta-analysis., in International clinical psychopharmacology, vol. 30, n. 4, luglio 2015, pp. 183–92, DOI:10.1097/yic.0000000000000078, PMID 25932596.
- Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders, in The World Journal of Biological Psychiatry, vol. 3, n. 4, Informa Healthcare, ottobre 2002, pp. 171–99, DOI:10.3109/15622970209150621, PMID 12516310.
- Cloos JM, Ferreira V, Current use of benzodiazepines in anxiety disorders, in Current Opinion in Psychiatry, vol. 22, n. 1, 2009, pp. 90–95, DOI:10.1097/YCO.0b013e32831a473d, PMID 19122540.
- Shorvon SD, Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959–2009, in Epilepsia, vol. 50, Suppl 3, marzo 2009, pp. 93–130, DOI:10.1111/j.1528-1167.2009.02042.x, PMID 19298435.
- Kraemer KL, Conigliaro J, Saitz R, Managing alcohol withdrawal in the elderly, in Drugs Aging, vol. 14, n. 6, 1999, pp. 409–25, DOI:10.2165/00002512-199914060-00002, PMID 10408740.
- Devlin JW, Roberts RJ, Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids, in Crit Care Clin, vol. 25, n. 3, luglio 2009, pp. 431–49, vii, DOI:10.1016/j.ccc.2009.03.003, PMID 19576523.
- Broscheit J, Kranke P, [The preoperative medication: background and specific indications for the selection of the drugs], in Anasthesiol Intensivmed Notfallmed Schmerzther, vol. 43, n. 2, febbraio 2008, pp. 134–43, DOI:10.1055/s-2008-1060547, PMID 18293248.
- Kamen L, Henney HR, Runyan JD, A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury, in Curr Med Res Opin, vol. 24, n. 2, febbraio 2008, pp. 425–39, DOI:10.1185/030079908X261113, PMID 18167175.
- Zimbroff DL, Pharmacological control of acute agitation: focus on intramuscular preparations, in CNS Drugs, vol. 22, n. 3, 2008, pp. 199–212, DOI:10.2165/00023210-200822030-00002, PMID 18278976.
- Gillies D, Beck A, McCloud A, Rathbone J, Gillies D, Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis, in Cochrane Database of Systematic Reviews, n. 4, 2005, pp. CD003079, DOI:10.1002/14651858.CD003079.pub2, PMID 16235313.
- (PT) Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI), Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros [Restless legs syndrome: diagnosis and treatment. Opinion of Brazilian experts], in Arq. Neuro-Psiquiatr., vol. 65, 3a, settembre 2007, pp. 721–7, DOI:10.1590/S0004-282X2007000400035, ISSN 0004-282X (WC · ACNP), PMID 17876423.
- Attard A, Ranjith G, Taylor D, Delirium and its treatment, in CNS Drugs, vol. 22, n. 8, agosto 2008, pp. 631–44, DOI:10.2165/00023210-200822080-00002, PMID 18601302.
- Gallegos J, Vaidya P, D'Agati D, Jayaram G, Nguyen T, Tripathi A, Trivedi JK, Reti IM, Decreasing adverse outcomes of unmodified electroconvulsive therapy: suggestions and possibilities, in J ECT, vol. 28, n. 2, giugno 2012, pp. 77–81, DOI:10.1097/YCT.0b013e3182359314, PMID 22531198.
- Stone KL, Ensrud KE, Ancoli-Israel S, Sleep, insomnia and falls in elderly patients, in Sleep Med., 9 Suppl 1, settembre 2008, pp. S18–22, DOI:10.1016/S1389-9457(08)70012-1, PMID 18929314.
- Riss J, Cloyd J, Gates J, Collins S, Benzodiazepines in epilepsy: pharmacology and pharmacokinetics, in Acta Neurol Scand, vol. 118, n. 2, agosto 2008, pp. 69–86, DOI:10.1111/j.1600-0404.2008.01004.x, PMID 18384456.
- Bond AJ, Drug-induced behavioural disinhibition: incidence, mechanisms and therapeutic implications, in CNS Drugs, vol. 9, n. 1, 1998, pp. 41–57, DOI:10.2165/00023210-199809010-00005.
- Golombok S, Moodley P, Lader M, 2, in Cognitive impairment in long-term benzodiazepine users, Psychological Medicine, vol. 18, May 1988, p. 365–74, DOI:10.1017/S0033291700007911, PMID 2899898.
- Nardi AE, Perna G, Clonazepam in the treatment of psychiatric disorders: an update, in Int Clin Psychopharmacol, vol. 21, n. 3, maggio 2006, pp. 131–42, DOI:10.1097/01.yic.0000194379.65460.a6, PMID 16528135.
- Fraser AD, Use and abuse of the benzodiazepines, in Ther Drug Monit, vol. 20, n. 5, 1998, pp. 481–9, DOI:10.1097/00007691-199810000-00007, PMID 9780123.
- Gaudreault P, Guay J, Thivierge RL, Verdy I, Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment, in Drug Saf, vol. 6, n. 4, 1991, pp. 247–65, DOI:10.2165/00002018-199106040-00003, PMID 1888441.
- Klein-Schwartz W, Oderda GM, Poisoning in the elderly. Epidemiological, clinical and management considerations, in Drugs Aging, vol. 1, n. 1, 1991, pp. 67–89, DOI:10.2165/00002512-199101010-00008, PMID 1794007.
- Serfaty M, Masterton G, Fatal poisonings attributed to benzodiazepines in Britain during the 1980s, in British Journal of Psychiatry, vol. 163, n. 1, 1994, pp. 128–9, DOI:10.1192/bjp.163.3.386, PMID 8104653.
- Seger DL, Flumazenil—treatment or toxin, in J Toxicol Clin Toxicol, vol. 42, n. 2, 2004, pp. 209–16, DOI:10.1081/CLT-120030946, PMID 15214628.
- Bain KT, Management of chronic insomnia in elderly persons, in Am J Geriatr Pharmacother, vol. 4, n. 2, 2006, pp. 168–92, DOI:10.1016/j.amjopharm.2006.06.006, PMID 16860264.
- Allain H, Bentué-Ferrer D, Polard E, Akwa Y, Patat A, Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review, in Drugs Aging, vol. 22, n. 9, 2005, pp. 749–65, DOI:10.2165/00002512-200522090-00004, PMID 16156679.
- Wang PS, Brookhart MA, Setoguchi S, Patrick AR, Schneeweiss S, Psychotropic medication use for behavioral symptoms of dementia, in Curr Neurol Neurosci Rep, vol. 6, n. 6, 2006, pp. 490–5, DOI:10.1007/s11910-006-0051-6, PMID 17074284.
- Hulse GK, Lautenschlager NT, Tait RJ, Almeida OP, Dementia associated with alcohol and other drug use, in Int Psychogeriatr, vol. 17, Suppl 1, 2005, pp. S109–27, DOI:10.1017/S1041610205001985, PMID 16240487.
- Sternbach LH, The benzodiazepine story, in Journal of Medicinal Chemistry, vol. 22, n. 1, 1979, pp. 1–7, DOI:10.1021/jm00187a001, PMID 34039.
- Miller NS, Gold MS, Benzodiazepines: reconsidered, in Adv Alcohol Subst Abuse, vol. 8, 3–4, 1990, pp. 67–84, DOI:10.1300/J251v08n03_06, PMID 1971487.
- Lemmer B, The sleep–wake cycle and sleeping pills, in Physiol Behav, vol. 90, 2–3, 2007, pp. 285–93, DOI:10.1016/j.physbeh.2006.09.006, PMID 17049955.
- Farré M, Camí J, Pharmacokinetic considerations in abuse liability evaluation, in Br J Addict., vol. 86, n. 12, dicembre 1991, pp. 1601–6, DOI:10.1111/j.1360-0443.1991.tb01754.x, PMID 1786493.
- Busto U, Sellers EM, Pharmacokinetic determinants of drug abuse and dependence. A conceptual perspective, in Clin Pharmacokinet., vol. 11, n. 2, 1986, pp. 144–153, DOI:10.2165/00003088-198611020-00004, PMID 3514044.
- Kintz P, Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes, in Anal Bioanal Chem, vol. 388, n. 7, 2007, pp. 1467–74, DOI:10.1007/s00216-007-1209-z, PMID 17340077.

parliament.uk

publications.parliament.uk

Peart R, Memorandum by Dr Reg Peart, su Minutes of Evidence, Select Committee on Health, House of Commons, UK Parliament, 1º giugno 1999. URL consultato il 27 maggio 2009.

psychiatryonline.com

Work Group on Panic Disorder, APA Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition (PDF), su psychiatryonline.com, gennaio 2009. URL consultato il 12 luglio 2009.

psychiatryonline.org

psychservices.psychiatryonline.org

Bogunovic OJ, Greenfield SF, Practical geriatrics: Use of benzodiazepines among elderly patients (PDF), in Psychiatr Serv, vol. 55, n. 3, 2004, pp. 233–5, DOI:10.1176/appi.ps.55.3.233, PMID 15001721.

rcpsych.org

pb.rcpsych.org

Paton C, Benzodiazepines and disinhibition: a review (PDF), in Psychiatr Bull R Coll Psychiatr, vol. 26, n. 12, 2002, pp. 460–2, DOI:10.1192/pb.26.12.460.

rxlist.com

Temazepam-Rxlist Pregnancy Category@

unibo.it

acnpsearch.unibo.it

(PT) Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI), Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros [Restless legs syndrome: diagnosis and treatment. Opinion of Brazilian experts], in Arq. Neuro-Psiquiatr., vol. 65, 3a, settembre 2007, pp. 721–7, DOI:10.1590/S0004-282X2007000400035, ISSN 0004-282X (WC · ACNP), PMID 17876423.

web.archive.org

American College of Obstetricians and Gynecologists Committee on Practice Bulletins—Obstetrics, ACOG Practice Bulletin no. 92: Use of psychiatric medications during pregnancy and lactation, in Obstet Gynecol, vol. 111, n. 4, aprile 2008, pp. 1001–20, DOI:10.1097/AOG.0b013e31816fd910, PMID 18378767. URL consultato il 29 aprile 2019 (archiviato dall'url originale il 6 luglio 2016).
American Geriatrics Society 2012 Beers Criteria Update Expert Panel, American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults (PDF), su guideline.gov, Agency for Healthcare Research and Quality, 2012. URL consultato il 24 ottobre 2015 (archiviato dall'url originale il 7 novembre 2015).
Technology Appraisal Guidance 77. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (PDF), su nice.org.uk, National Institute for Clinical Excellence, aprile 2004. URL consultato il 26 luglio 2009 (archiviato dall'url originale il 3 dicembre 2008).
Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M, Manifestations and Management of Chronic Insomnia in Adults. Summary, Evidence Report/Technology Assessment: Number 125 (PDF), su ahrq.gov, Agency for Healthcare Research and Quality, giugno 2005. URL consultato il 23 ottobre 2015 (archiviato dall'url originale il 14 maggio 2012).
McIntosh A, Cohen A, Turnbull N, Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder (PDF), su nice.org.uk, National Collaborating Centre for Primary Care, 2004. URL consultato il 16 giugno 2009 (archiviato dall'url originale il 19 febbraio 2009).
Canadian Psychiatric Association, Clinical practice guidelines. Management of anxiety disorders (PDF), in Can J Psychiatry, vol. 51, 8 Suppl 2, luglio 2006, pp. 51S–55S, PMID 16933543. URL consultato l'8 agosto 2009 (archiviato dall'url originale il 14 luglio 2010).
Stokes T, Shaw EJ, Juarez-Garcia A, Camosso-Stefinovic J, Baker R, Clinical Guidelines and Evidence Review for the Epilepsies: diagnosis and management in adults and children in primary and secondary care (PDF), London, Royal College of General Practitioners, ottobre 2004, pp. 61, 64–65. URL consultato il 2 giugno 2009 (archiviato dall'url originale il 20 maggio 2009).
Stokes T, Shaw EJ, Juarez-Garcia A, Camosso-Stefinovic J, Baker R, Clinical Guidelines and Evidence Review for the Epilepsies: diagnosis and management in adults and children in primary and secondary care (Appendix B) (PDF), su nice.org.uk, London, Royal College of General Practitioners, ottobre 2004, p. 432. URL consultato il 2 giugno 2009 (archiviato dall'url originale il 27 novembre 2011).
Prater CD, Miller KE, Zylstra RG, Outpatient detoxification of the addicted or alcoholic patient, in American Family Physician, vol. 60, n. 4, settembre 1999, pp. 1175–83, PMID 10507746. URL consultato il 23 ottobre 2015 (archiviato dall'url originale il 6 giugno 2011).
Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C, Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice (PDF), in Mov Disord, vol. 23, n. 16, dicembre 2008, pp. 2267–302, DOI:10.1002/mds.22254, PMID 18925578 (archiviato dall'url originale il 29 dicembre 2009).
(EN) benzodiazepines-oral, su medicinenet.com. URL consultato il 24 ottobre 2015 (archiviato dall'url originale il 14 aprile 2008).
Stewart SA, The effects of benzodiazepines on cognition (PDF), in J Clin Psychiatry, vol. 66, Suppl 2, 2005, pp. 9–13, PMID 15762814 (archiviato dall'url originale il 15 luglio 2011).
Longo LP, Johnson B, Addiction: Part I. Benzodiazepines—side effects, abuse risk and alternatives, in American Family Physician, vol. 61, n. 7, aprile 2000, pp. 2121–8, PMID 10779253. URL consultato il 23 ottobre 2015 (archiviato dall'url originale il 12 maggio 2008).
Otto MW, Bruce SE, Deckersbach T, Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need (PDF), in J Clin Psychiatry, vol. 66, Suppl 2, 2005, pp. 34–8, PMID 15762818 (archiviato dall'url originale il 15 luglio 2011).
Chouinard G, Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound (PDF), in J Clin Psychiatry, vol. 65, Suppl 5, 2004, pp. 7–12, PMID 15078112 (archiviato dall'url originale il 15 luglio 2011).
Lal R, Gupta S, Rao R, Kattimani S, Emergency management of substance overdose and withdrawal, in Substance Use Disorder, World Health Organization (WHO), 2007, p. 82. URL consultato il 6 giugno 2009 (archiviato dall'url originale il 13 giugno 2010).
«Generally, a longer-acting benzodiazepine such as chlordiazepoxide or diazepam is used and the initial dose titrated downward»
Iqbal MM, Sobhan T, Ryals T, Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant (PDF), in Psychiatr Serv, vol. 53, n. 1, 2002, pp. 39–49, DOI:10.1176/appi.ps.53.1.39, PMID 11773648 (archiviato dall'url originale il 27 luglio 2011).
Home Office (2005). Explanatory memorandum to the misuse of drugs and the misuse of drugs Archiviato il 16 dicembre 2010 in Internet Archive. (supply to addicts) (amendment) regulations 2005.No.2864. Accessed 20–10–03
List of drugs currently controlled under the misuse of drugs legislation (PDF), su homeoffice.gov.uk, UK Government Home Office, 25 ottobre 2010. URL consultato il 30 gennaio 2011 (archiviato dall'url originale il 18 febbraio 2011).

webcitation.org

Clinical Guideline 22 (amended). Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care (PDF), su nice.org.uk, National Institute for Health and Clinical Excellence, 2007, pp. 23–25. URL consultato l'8 agosto 2009 (archiviato dall'url originale il 6 giugno 2012).
Barbui C, Cipriani A, Proposal for the inclusion in the WHO Model List of Essential Medicines of a selective serotonin-reuptake inhibitor for Generalised Anxiety Disorder (PDF), su who.int, WHO Collaborating Centre for Research and Training in Mental Health, 2009. URL consultato il 23 giugno 2009 (archiviato dall'url originale il 6 giugno 2012).
Scottish Intercollegiate Guidelines Network, Diagnosis and management of epilepsy in adults (PDF), su sign.ac.uk, 2005, pp. 17–9. URL consultato il 5 giugno 2009 (archiviato dall'url originale il 27 giugno 2012).
Committee on Safety of Medicines, Benzodiazepines, dependence and withdrawal symptoms (PDF), su mhra.gov.uk, Medicines and Healthcare products Regulatory Agency, 1988. URL consultato il 28 maggio 2009 (archiviato dall'url originale il 6 giugno 2012).

whoindia.org

Lal R, Gupta S, Rao R, Kattimani S, Emergency management of substance overdose and withdrawal, in Substance Use Disorder, World Health Organization (WHO), 2007, p. 82. URL consultato il 6 giugno 2009 (archiviato dall'url originale il 13 giugno 2010).
«Generally, a longer-acting benzodiazepine such as chlordiazepoxide or diazepam is used and the initial dose titrated downward»

worldcat.org

(PT) Grupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI), Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros [Restless legs syndrome: diagnosis and treatment. Opinion of Brazilian experts], in Arq. Neuro-Psiquiatr., vol. 65, 3a, settembre 2007, pp. 721–7, DOI:10.1590/S0004-282X2007000400035, ISSN 0004-282X (WC · ACNP), PMID 17876423.